The Physician Payment Sunshine Act, Section 6002 of the Patient Protection and Affordable Care Act, which will require pharmaceutical companies to track and publicly report what they spend on healthcare providers, is still in limbo as of the final days of 2012. The Centers for Medicare and Medicaid Services completed the final rule and submitted it to the Office of Management and Budget for review in late November. The Office of Information and Regulatory Affairs is evaluating the final ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.

Already registered? here.